DAB.bio
Unlocking the promise of biomanufacturing by transforming the economics of production with our patented FAST bioreactor
DAB is a leading expert in Separation Technology of oil based fermentation. Our unique and patented FAST technology (Fermentation Accelerated by Separation Technology) enables continuous fermentation to offer unit cost reductions of 30% or more. By continuously removing product or inhibitors from the fermentation process, FAST extends the run time and increases unit production. FAST has become one the most significant fermentation innovations of the past decade. This technology can easily be implemented in new and existing installations, allowing for rapid application.
The global focus on synthetic biology has delivered several breakthrough routes to replace fossil-based chemicals with sustainable bio-based alternatives. High manufacturing costs currently hamper the large-scale manufacturing of many of these alternatives. FAST addresses this issue head-on. It is the largest contributor to lowering manufacturing costs, thereby facilitating large-scale deployment of many bio-based chemicals.
DAB has a highly skilled workforce and is supported by driven and capable investors.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
Interview with Professor Jack Pronk: About the Intersection of Academia and Entrepreneurship in Industrial Biotechnology
Jack Pronk is full professor in Industrial Microbiology and the head of the Biotechnology Department at TU Delft. His research focuses on understanding enhancing microbial performance in industrial processes by integrating quantitative physiology, genomics, synthetic biology, and evolutionary engineering. His team's work on yeast engineering for alcoholic fermentation and improving ethanol yields is applied on an industrial scale. Recently, he was awarded the prestigious Novozymes Prize, given annually since 1963 for outstanding European research in biotechnology. Planet B.io had the opportunity to sit down with Professor Pronk to discuss his views on entrepreneurship in industrial biotechnology.
Hologenomix | Pioneering Multi-Omics Profiles for Early Disease Diagnosis
Hologenomix, the newest resident at Planet B.io, is creating multi-omics profiles from human biofluids. As the first user of our Shared Service Lab, Hologenomix is poised to revolutionize early disease diagnosis through DNA analysis. Co-founders David Calderon Franco and Eric van der Toorn share insights into their journey and vision.
Fishway: Innovating the Future of Fish through Cellular Aquaculture
Fishway, member of Planet B.io, is the new kid on the block in the field of cellular aquaculture. Founded by Nina Coolsaet and Sam Van de Velde, Fishway aims to address the pressing challenges faced by the traditional fishing industry, such as overfishing, pollution, and the decline in biodiversity. By producing fish-derived ingredients, Fishway hopes to offer a sustainable alternative that preserves the nutritional benefits of fish without the environmental downsides.